Cargando…
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this...
Autores principales: | Ng, Kenrick, Vinnakota, Krishna, Sharma, Anand, Kelly, John, Dasgupta, Prokar, Vasdev, Nikhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745709/ https://www.ncbi.nlm.nih.gov/pubmed/33335321 http://dx.doi.org/10.1038/s41585-020-00419-z |
Ejemplares similares
-
Biomarkers in Bladder Cancer Surveillance
por: Sugeeta, Sukumar S., et al.
Publicado: (2021) -
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
por: Chhaya, Saachi, et al.
Publicado: (2023) -
Cancer diagnostic delay in the COVID-19 era: what happens next?
por: Hamilton, William
Publicado: (2020) -
Secondary neoplasms of the urinary bladder-clinical management and oncological outcomes
por: El-Taji, Omar, et al.
Publicado: (2021) -
The Emerging Role of Artificial Intelligence in the Fight Against COVID-19
por: Ghose, Aruni, et al.
Publicado: (2020)